Labcorp raises 2026 guidance after 5.8% Q2 revenue growth and 14.9% adjusted EPS rise
Labcorp reported second-quarter 2026 revenue of $3.73 billion, up 5.8% from a year earlier, and diluted EPS of $3.64, up from $2.84. The company raised its full-year 2026 adjusted EPS guidance to $18.10 to $18.55 and increased its share repurchase authorization by $1.0 billion, leaving $1.4 billion remaining, which points to stronger results and more capital returned to shareholders.
Key points
- Q2 2026 revenue was $3.73 billion versus $3.53 billion, up 5.8%
- Adjusted EPS was $4.99 versus $4.35, up 14.9%; diluted EPS was $3.64 versus $2.84
- 2026 adjusted EPS guidance raised to $18.10 to $18.55, up 30 cents at the midpoint
- Share repurchase authorization increased by $1.0 billion, bringing remaining authorization to $1.4 billion
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.